Search research articles
Contact Us
Filters
Showing results (161-170 of 298) with videos related to
Page
of 30
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 21, 2023
Multicenter Harmonization Study of Pan-Trk Immunohistochemistry for the Detection of NTRK3 Fusions
Julien Adam, Nolwenn Le Stang, Arnaud Uguen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 22, 2019
Allogeneic Stem Cell Transplantation in Therapy-Related Myelodysplasia after Autologous Transplantation for Lymphoma: A Retrospective Study of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy
Daniel Jaimes-Albornoz, Lionel Mannone, Stéphanie Nguyen-Quoc, et al.
Blood
|
March 17, 2024
Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee
Francesco Onida, Nico Gagelmann, Yves Chalandon, et al.
Haematologica
|
August 3, 2014
Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
Vissal David Kheav, Marc Busson, Catherine Scieux, et al.
Blood
|
March 20, 2023
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation
Nico Gagelmann, Anita Badbaran, Rachel B Salit, et al.
Haematologica
|
April 3, 2016
Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults
Rohtesh S Mehta, Regis Peffault de Latour, Todd E DeFor, et al.
ESC Heart Failure
|
December 28, 2020
PRADOC: a trial on the efficiency of a transition care management plan for hospitalized patients with heart failure in France
Claire Duflos, Jean-Philippe Labarre, Roxana Ologeanu, et al.
Bone Marrow Transplantation
|
March 22, 2024
Transplantation for myelofibrosis patients in the ruxolitinib era: a registry study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire
Sara Villar, Sylvie Chevret, Xavier Poire, et al.
Bone Marrow Transplantation
|
May 21, 2024
Anti-T-lymphocyte globulin improves GvHD-free and relapse-free survival in myelofibrosis after matched related or unrelated donor transplantation
Kristin Rathje, Nico Gagelmann, Rachel B Salit, et al.
British Journal of Haematology
|
December 8, 2010
Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
Marie Robin, Reza Tabrizi, Mohamad Mohty, et al.
Page
of 30
Search research articles
Search
Showing results (161-170 of 298) with videos related to
Sort By:
Page
of 30
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 21, 2023
Multicenter Harmonization Study of Pan-Trk Immunohistochemistry for the Detection of NTRK3 Fusions
Julien Adam, Nolwenn Le Stang, Arnaud Uguen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 22, 2019
Allogeneic Stem Cell Transplantation in Therapy-Related Myelodysplasia after Autologous Transplantation for Lymphoma: A Retrospective Study of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy
Daniel Jaimes-Albornoz, Lionel Mannone, Stéphanie Nguyen-Quoc, et al.
Blood
|
March 17, 2024
Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee
Francesco Onida, Nico Gagelmann, Yves Chalandon, et al.
Haematologica
|
August 3, 2014
Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
Vissal David Kheav, Marc Busson, Catherine Scieux, et al.
Blood
|
March 20, 2023
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation
Nico Gagelmann, Anita Badbaran, Rachel B Salit, et al.
Haematologica
|
April 3, 2016
Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults
Rohtesh S Mehta, Regis Peffault de Latour, Todd E DeFor, et al.
ESC Heart Failure
|
December 28, 2020
PRADOC: a trial on the efficiency of a transition care management plan for hospitalized patients with heart failure in France
Claire Duflos, Jean-Philippe Labarre, Roxana Ologeanu, et al.
Bone Marrow Transplantation
|
March 22, 2024
Transplantation for myelofibrosis patients in the ruxolitinib era: a registry study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire
Sara Villar, Sylvie Chevret, Xavier Poire, et al.
Bone Marrow Transplantation
|
May 21, 2024
Anti-T-lymphocyte globulin improves GvHD-free and relapse-free survival in myelofibrosis after matched related or unrelated donor transplantation
Kristin Rathje, Nico Gagelmann, Rachel B Salit, et al.
British Journal of Haematology
|
December 8, 2010
Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
Marie Robin, Reza Tabrizi, Mohamad Mohty, et al.
Page
of 30